Product NDC: | 0904-5952 |
Proprietary Name: | Spironolactone |
Non Proprietary Name: | Spironolactone |
Active Ingredient(s): | 50 mg/1 & nbsp; Spironolactone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0904-5952 |
Labeler Name: | Major Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040353 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091102 |
Package NDC: | 0904-5952-06 |
Package Description: | 50 TABLET in 1 BOX, UNIT-DOSE (0904-5952-06) |
NDC Code | 0904-5952-06 |
Proprietary Name | Spironolactone |
Package Description | 50 TABLET in 1 BOX, UNIT-DOSE (0904-5952-06) |
Product NDC | 0904-5952 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Spironolactone |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091102 |
Marketing Category Name | ANDA |
Labeler Name | Major Pharmaceuticals |
Substance Name | SPIRONOLACTONE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |